Literature DB >> 4021311

Calcium metabolism in uremic nephrocalcinosis: preventive effect of verapamil.

M S Goligorsky, C Chaimovitz, J Rapoport, J Goldstein, R Kol.   

Abstract

The aim of the present study was to examine calcium metabolism of the renal cortex in experimental chronic renal failure, together with morphologic criteria of nephrocalcinosis and to determine the effect of chronic verapamil administration on these parameters. In subtotally nephrectomized (SNX) rats 3 weeks after surgery, renal cortical calcium content increased more than two-fold. 45Ca incorporation into renal cortical slices in SNX revealed a 35% increase, associated with a 50% increase in a lanthanum-resistant fraction of 45Ca uptake. Radiocalcium wash-out curves in this group demonstrated abnormal retention of the isotope for up to 30 min of incubation. In contrast, radiocalcium incorporation and wash-out in SNX rats chronically treated with verapamil were similar to that obtained in the sham group. Verapamil administration significantly reduced, but did not normalize, renal cortical calcium content. Von Kossa staining demonstrated the deposition of calcium in the renal parenchyma of SNX rats. Ultrastructurally, it was accompanied by mitochondrial disorganization and calcification, as well as by the tubular basement membrane destruction and mineralization. These morphologic patterns of nephrocalcinosis were significantly ameliorated in SNX rats treated with verapamil. We conclude that chronic verapamil administration results in amelioration of uremic nephrocalcinosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4021311     DOI: 10.1038/ki.1985.79

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

1.  Renal protective effects of calcium antagonists?

Authors:  J H Bauer
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

2.  [Effect of a calcium inhibitor, verapamil, on the development of heterotopic ossifications. An experimental study in rats].

Authors:  J Duriez; B Flautre; M C Blary; R Duriez
Journal:  Int Orthop       Date:  1990       Impact factor: 3.075

3.  Evidence for renal ischaemia as a cause of mercuric chloride nephrotoxicity.

Authors:  G Girardi; M M Elías
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

Review 4.  Renal effects of antihypertensive drugs.

Authors:  W A Schlueter; D C Batlle
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

5.  The calcium channel blocker nisoldipine delays progression of chronic renal failure in humans (preliminary communication).

Authors:  H E Eliahou; D Cohen; A Ben-David; D Herzog; I Serban; S Gavendo; S Kapuler; N Kogan; B Hellberg
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

6.  Effects of the calcium channel blocker nifedipine on epiphyseal growth plate and bone turnover: a study in rabbit.

Authors:  J Duriez; B Flautre; M C Blary; P Hardouin
Journal:  Calcif Tissue Int       Date:  1993-02       Impact factor: 4.333

7.  Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study.

Authors:  Rupal Mehta; Xuan Cai; Jungwha Lee; Dawei Xie; Xue Wang; Julia Scialla; Amanda H Anderson; Jon Taliercio; Mirela Dobre; Jing Chen; Michael Fischer; Mary Leonard; James Lash; Chi-Yuan Hsu; Ian H de Boer; Harold I Feldman; Myles Wolf; Tamara Isakova
Journal:  Am J Kidney Dis       Date:  2019-12-19       Impact factor: 8.860

8.  The hypertension drug, verapamil, activates Nrf2 by promoting p62-dependent autophagic Keap1 degradation and prevents acetaminophen-induced cytotoxicity.

Authors:  Da Hyun Lee; Jeong Su Park; Yu Seol Lee; Su Haeng Sung; Yong-Ho Lee; Soo Han Bae
Journal:  BMB Rep       Date:  2017-02       Impact factor: 4.778

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.